Clinical trial
Effect of Losartan on Retinal Endothelial Function in Patients With Essential…
NCT00152633 · University of Erlangen-Nürnberg Medical School, Other · Withdrawn
Key facts
| NCT number | NCT00152633 |
|---|---|
| Title | Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension |
| Official title | Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Losartan, Metoprolol |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 6, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: